Biopharmaceutical characterization of oral theophylline and aminophylline tablets. Quantitative correlation between dissolution and bioavailability studies

European Journal of Pharmaceutics and Biopharmaceutics

Volumn 50, Issue 2, 2000, Pages 301-306

  Varshosaz, Jaleh ^a,b   Ghafghazi, Taghi ^a   Raisi, Ahmad ^a   Falamarzian, Mahmood ^a  

^a ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b Isfahan Pharmaceutical Sciences Research Center   (Iran)

Author keywords

Asthma; Bioavilability; Dissolution; Pharmacokinetics; Theophylline

Indexed keywords

AMINOPHYLLINE; THEOPHYLLINE;

AREA UNDER THE CURVE; ARTICLE; ASTHMA; COMPARTMENT MODEL; CONTROLLED STUDY; CORRELATION FUNCTION; DRUG ABSORPTION; DRUG BIOAVAILABILITY; DRUG SOLUBILITY; FLUORESCENCE POLARIZATION IMMUNOASSAY; HUMAN; HUMAN EXPERIMENT; IN VIVO STUDY; MALE; NORMAL HUMAN;

ADMINISTRATION, ORAL; ADULT; AMINOPHYLLINE; AREA UNDER CURVE; BIOLOGICAL AVAILABILITY; HUMANS; MALE; SOLUBILITY; TABLETS; THEOPHYLLINE;

EID: 0033843842     PISSN: 09396411     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0939-6411(00)00074-6     Document Type: Article

References (20)

1. H.J. Myron, M. Robertand, K. Gerald, Clinical experience with theophylline. Relationships between dosage, serum concentration and toxicity, J. Am. Med. Assoc. 235 (18) (1976) 1983-1986.
2. R.E. Notari, Biopharmaceutics and clinical pharmacokinetics, an introduction, 4th ed., Marcel Dekker, Inc, New York, 1987 183/ 388/180.
3. E.G. Ellis, R. Koysooko, G. Levy, Pharmacokinetics of theophylline in children with asthma, Pediatrics 58 (1976) 542.
4. G.M.R. Vandenbossche, R.A. Lefebvre, A.G. DE Wilde, J.P. Remon, Performance of a modified starch hydrophillic matrix for the sustained release of theophylline in healthy volunteers, J. Pharm. Sci. 81 (3) (1992) 245-248.
5. L. Shan-Yang, K. Yuh-Horng, C. Hsiao-Ning, Preliminary evaluation of the correlation between in vitro release and in vivo bioavailability of two aminophylline slow-release tablets, J. Pharm. Sci. 79 (4) (1990) 326-330.
6. A. El-Yazigi, R.J. Sawchuk, In vitro-in vivo correlation and dissolution studies with oral theophylline dosage forms, J. Pharm. Sci. 74 (2) (1985) 161-164.
7. W.A. Ritschel, H.P. Koch, G.J. Alcorn, In vitro-in vivo correlation with SR theophylline preparations, Methods Find. Exp. Clin. Pharmacol. 6 (10) (1984) 609-618.
8. D. Brockmeir, In vitro-in vivo correlation, a time scaling problem, Evaluation of mean times, Arzneim.- Forsch 34 (1984) 1604-1607.
9. B.H. Chung, C.K. Shim, Dissolution of theophylline from sustained-release dosage forms and correlation with saliva bioavailability parameters, J. Pharm. Sci. 76 (10) (1987) 784-787.
10. M.E. Jolley, S.D. Stroupe, K.S. Schwenzer, C.J. Wang, M.Lu. Steffes, H.D. Hill, D.M. Kelso, Fluorescence polarization immunoassay, an automated system for therapeutic drug determination, Clin. Chem. 27 (9) (1981) 1575-1579.
11. J.G. Wagner. Fundamentals of Clinical Pharmacokinetics, 1st ed., Drug Intelligence, Hamilton, IL, 1975, pp. 174-176.
12. L. Shan-Yang, Y. Juei-Chyi, Bioavailability studies of theophylline ethylcellulose microcapsules prepared by using ethyl-vinyl acetate copolymer as a coacervation inducing agent, J. Pharm. Sci. 76 (3) (1987) 219-223.
13. K.J. Simons, E.M. Frith, E.R. Simons, Dissolution and bioavailability studies of whole and halved sustained-release theophylline tablets, J. Pharm. Sci. 71 (5) (1982) 505-511.
14. R.A. Upton, J.F. Thiercelin, S. Riegelman, Intraindividual variability in theophylline pharmacokinetics: statistical verification in 39 of 60 healthy young adults, J. Pharmacok. Biopharm. 10 (1) (1982) 123-133.
15. J. Varshosaz, T. Ghafghazi, A. Raisi, M. Falamarzian, Study the dissolution rate of some theophylline and aminophylline tablets by rotating basket and paddle method, Res. Bull. Isfahan Univ. (2000) in press.
16. E.G. Ellis, R. Koysooko, G. Levy, Pharmacokinetics of theophylline in children with asthma, Pediatrics 58 (1976) 542.
17. P.A. Mitenko, R.I. Ogilvie, Rational intravenous doses of theophylline, N. Engl. J. Med. 289 (1973) 600-603.
18. P. Rangsithienchai, R.W. Newcomb, Aminophylline therapy in children: guidelines for dosage forms, J. Pediatr. 91 (2) (1977) 325-330.
19. J.G. Wagner, Intrasubject variation in elimination half lives of drugs which are appreciably metabolized, J. Pharmaco. Biopharm. 1 (1973) 165-173.
20. J.G. Hardman, L.E. Limbird, P.B. Molinoff, R.W. Ruddon, A. Goodman, The Pharmacological Basis of Therapeutics, Me Graw-Hill, New York, 1996 p. 676.